Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of CES1 Genotype on Metabolism of Methylphenidate

NCT02147535 is registered in ClinicalTrials.gov with Bispebjerg Hospital as lead sponsor.

NCT NCT02147535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02147535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of CES1 Genotype on Metabolism of Methylphenidate
Lead sponsor
Bispebjerg Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2014
Completion date
Not reported
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carboxylesterase 1 (ces1) genotype, ces1 activity